Combining Behavioral and Pharmacological Treatments for Obesity
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Weight‐loss medications are currently recommended for use only as an adjunct to diet, exercise, and behavior modification. Little, however, is known about the benefits of combining behavioral and pharmacological therapies or about the mechanisms that would make these combined approaches more effective than either used alone. This article reviews the effects of adding pharmacotherapy (i.e., principally sibutramine and orlistat) to a modest program of lifestyle modification. Studies revealed that the addition of medication typically improved short‐ and long‐term weight loss compared with lifestyle modification alone. The best results, however, were obtained when medications were combined with an intensive, group program of lifestyle modification. The two approaches may have additive effects; behavioral treatment seems to help obese individuals control the external (i.e., food‐related) environment, whereas pharmacotherapy may control the internal environment by reducing hunger, cravings, or nutrient absorption. The article examines possible methods of sequencing behavioral and pharmacological therapies and offers suggestions for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sjöström, L., Rissanen, A., Andersen, T., Boldrin, M., Golay, A., Koppeschaar, H. P., & Krempf, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11509-4 · Cited by 1,237
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947 · cited 2×
“Investigations with orlistat found that �60% to 75% of the weight lost during the first year of treatment was maintained at the end of the second year (while patients remained on medication), re sulting in a 5% to 8% weight loss at this time (49,51,70,72).”
BackgroundUsing Internet technology to deliver a behavioral weight loss program
Tate, D. F. (2001) · JAMA · doi:10.1001/jama.285.9.1172 · Cited by 925 · cited 1×
“There are a number of promising new methods for disseminating be havioral treatment, including internet-administered inter ventions (101).”
MethodEffect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Jakicic, J. M., Winters, C., Lang, W., & Wing, R. R. (1999) · JAMA · doi:10.1001/jama.282.16.1554 · Cited by 536
Rössner, S., Sjöström, L., Noack, R., Meinders, A. E., Noseda, G., & Study, O. B. O. T. E. O. O. (2000) · Obesity Research · doi:10.1038/oby.2000.8 · Cited by 476 · cited 2×
“Investigations with orlistat found that �60% to 75% of the weight lost during the first year of treatment was maintained at the end of the second year (while patients remained on medication), re sulting in a 5% to 8% weight loss at this time (49,51,70,72).”
BackgroundFoster, G. D., Wadden, T. A., Vogt, R. A., & Brewer, G. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.1.79 · Cited by 447
Self-citationOrlistat in the long-term treatment of obesity in primary care settings.
Hauptman, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.160 · Cited by 367 · cited 4×
“Investigations with orlistat found that �60% to 75% of the weight lost during the first year of treatment was maintained at the end of the second year (while patients remained on medication), re sulting in a 5% to 8% weight loss at this time (49,51,70,72).”
BackgroundInfluentialEffects of four maintenance programs on the long-term management of obesity
Perri, M. G., McAllister, D. A., Gange, J. J., Jordan, R. C., McAdoo, W. G., & Nezu, A. M. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.4.529 · Cited by 304 · cited 1×
“Atten dance of maintenance sessions declines over time, and once treatment is terminated, patients regain weight (23).”
BackgroundReinforcing Value of Food in Obese and Non-obese Women
SAELENS, B. E., & EPSTEIN, L. H. (1996) · Appetite · doi:10.1006/appe.1996.0032 · Cited by 288
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287 · cited 1×
“(84) randomly assigned obese subjects who had lost �8% of their initial body weight (by diet and exercise alone) to placebo or orlistat, which was administered for 1 year in combination with a weight-maintenance diet.”
Fujioka, K., Seaton, T. B., Rowe, E., Jelinek, C. A., Raskin, P., Lebovitz, H. E., Weinstein, S. P., & Group, T. S. C. S. (2000) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00081.x · Cited by 244
Wing, R. R., Blair, E., Marcus, M., Epstein, L. H., & Harvey, J. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90302-6 · Cited by 228
Comparison of continuous and intermittent anorectic therapy in obesity.
Munro, J. F., MacCuish, A. C., Wilson, E. M., & Duncan, L. J. (1968) · BMJ · doi:10.1136/bmj.1.5588.352 · Cited by 215 · cited 1×
“(90) but came to a different conclusion.”
Jeffery, R. W., Wing, R. R., Thorson, C., & Burton, L. R. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.5.777 · Cited by 179
Behavioral treatment of obesity: thirty years and counting
Wilson, G. T. (1994) · Advances in Behaviour Research and Therapy · doi:10.1016/0146-6402(94)90002-7 · Cited by 159 · cited 1×
“As others have suggested (27), it may be asking too much for overweight individuals to exert continuous control in the face of unremitting biological factors and an environment that supplies an abundance of ready-made high-calorie, high-fat foods, as well as a multitude of energy-saving devices.”
BackgroundHow “blind” are double-blind studies?
Margraf, J., Ehlers, A., Roth, W. T., Clark, D. B., Sheikh, J., Agras, W. S., & Taylor, C. B. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.184 · Cited by 135
Cited by
Randomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity
Wadden, T. A., Berkowitz, R. I., Womble, L. G., Sarwer, D. B., Phelan, S., Cato, R. K., Hesson, L. A., Osei, S. Y., Kaplan, R., & Stunkard, A. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050156 · Cited by 794
Self-citationAre Mood Disorders and Obesity Related? A Review for the Mental Health Professional
McElroy, S. L., Kotwal, R., Malhotra, S., Nelson, E. B., Keck, P. E., & Nemeroff, C. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0507 · Cited by 652
Behavioral treatment of obesity
Butryn, M. L., Webb, V., & Wadden, T. A. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.08.006 · Cited by 636
Self-citationA review of psychosocial pre‐treatment predictors of weight control
Teixeira, P. J., Going, S. B., Sardinha, L. B., & Lohman, T. G. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00166.x · Cited by 449
Lifestyle modification for the management of obesity
Wadden, T. A., Butryn, M. L., & Wilson, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.051 · Cited by 406
Self-citation
Metadata
- Authors
- Phelan, S., & Wadden, T. A.
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 2002-06
- Volume
- 10
- Issue
- 6
- Pages
- 560-574
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W2002905061
- Cited by
- 73
- References
- 18
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.